Innovation Pharmaceuticals Inc (IPIX)

[BioHedge]

Out of whack expectations. Leo's life blood for four years has been his stock price. It's how he's financed CTIX and he is given to using language that conveys more than what he might have meant. One trait of most entrepreneurs have, is they tend to be incredibly optimistic. It is something that is needed to drive change. That optimism sometime leads to underestimating timelines or being too eager to please. We often tell our companies that it's going to take 3x as long and cost 2x as much as what they think to reach their projections. For the reasons above, I sometimes think Leo, wanting to express his excitement, says too much and/or with too strong of adjectives. (see "momentous" in the November release). That said, CTIX is still doing exceptionally well, both in drug development and corporate progress.

I'm still waiting for Brilacidin bottom line P2b results and will only add once they or similar news from Kevetrin or Purisol trials are released. I believe that Leo has the bottom line results but the data analysis sounds like it is more complex than I had anticipated.

Hope everyone has a great Holiday Season. Looking forward to reports from the Bio-tech showcase in Jan.